Embracing the Promise of Natural Killer Cells in the Fight Against Cancer
The Bio Report
00:00
Liver Cancer - What's the Need?
In editing these cells, do you ever edit them to target specific types of tumor cells? Yes. In the insertion of car the chimeric antegen receptor is like a g p s that targets te sall a to specific a tumor. You're pursuing a number of candidates. Your lead candidates are in development for liver cancer and other solid tumors. Why start with liver cancer? What's the need and opportunity? No, sure, that's a very good the first element of he response is that in many companies are technology platform companies. We're a product woretic product companies. But argo is to addressa unmatmetical need.
Transcript
Play full episode
